STAT+: Pharmalittle: We’re reading about a Lilly obesity drug trial, statistics for an Alzheimer’s drug, and more
Stat News • 5/21/2026
Summary
No summary yet.
Advertisement
Lindy Score Breakdown (V4.2)
3h
Age
1
Sources
from cluster
1
Hours Since Seen
Final Score12/100
CategoryAntiLindy
StatusActive
Recency Multiplier99% (0.5^1/48)
Hero EligibleYes
Story Timeline
- 2026-05-21STAT+: Pharmalittle: We’re reading about a Lilly obesity drug trial, statistics for an Alzheimer’s drug, and more (current)
Score BreakdownRisk 70
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: Breaking news - too recent to assess longevity
Stories gain Lindy status through source reputation, network consensus, and time survival.
Same Story from 2 sources
Related Stories
Breaking Similar stories
STAT+: Pharmalittle: We’re reading about biotech investors’ mood, a former FDA head’s confidence, and more
Stat News • 1 day ago
STAT+: Lilly’s ‘triple-G’ drug leads to bariatric-surgery levels of weight loss in trial
Stat News • Today
STAT+: Pharmalittle: We’re reading about a Supreme Court setback for pharma, TrumpRx expands and much more
Stat News • 2 days ago
STAT+: Pioneering trial for treating genetic disease before birth nears reality
Stat News • Today
STAT+: Eli Lilly tops prominent rankings on pharma R&D performance
Stat News • 2 days ago
STAT+: Elevance executive ordered to testify in Medicare Advantage fraud case
Stat News • Today
STAT+: Acting head of NIH’s infectious disease institute reported to have stepped down
Stat News • Today
STAT+: 1 in 8 women drink during pregnancy. Experts dread the consequences
Stat News • 2 days ago
STAT+: A new ranking of pharma companies by R&D performance
Stat News • 2 days ago
Opinion: STAT+: Dark times ahead at the FDA
Stat News • Today
